Ropsacitinib

SI-5509

Ropsacitinib, >98% (HPLC)

CAS No. : [2127109-84-4]

Synonyms : PF-06826647

IUPAC Name : (1r,3r)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutane-1-carbonitrile

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 20 September 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
Note: Ropsacitinibis not in stock but can be available through custom synthesis. The estimated lead-time is 4-6 weeks. The product will be characterized by NMR and Mass analysis. Purity (HPLC) is usually >98%. COA, QC data and SDS will be provided along with the product. For information on pricing and availability please contact us at sales@syninnova.com or Request A Quote. We respond promptly. Thank You!

Applications : Ropsacitinib is an orally administered, tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and inflammatory bowel disease.

References : Wrobleski Y. S. et al.: et al. J. Med Chem., 62(20), 8973-8995, 2019; Gerstenberger S. B. et al. J. Med Chem., 63(22), 13561-13577, 2020.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.